Archived Clinical Summary
Aspirin for the Prevention of Cardiovascular Disease: Preventive Medication
Originally published on: January 15, 2014
This recommendation statement is currently archived and inactive. It should be used for historical purposes only. Click here for copyright and source information .
Disclaimer:Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services.
Archived: Clinical Summary of U.S. Preventive Services Task Force Recommendation
This document is a summary of the 2009 recommendation of the U.S. Preventive Services Task Force (USPSTF) on aspirin for the prevention of cardiovascular disease. This summary is intended for use by primary care clinicians.
Select for copyright and source information.
Age 45-79 Years
Age 55-79 Years
Age <45 Years
Age <55 Years
|Men & Women
Age ≥80 Years
|Recommendation||Encourage aspirin use when potential CVD benefit (MIs prevented) outweighs potential harm of GI hemorrhage.||Encourage aspirin use when potential CVD benefit (strokes prevented) outweighs potential harm of GI hemorrhage.||Do not encourage aspirin use for MI prevention.||Do not encourage aspirin use for stroke prevention.||No Recommendation|
|Grade: A||Grade: D||Grade: I
|How to Use This Recommendation||
|Risk Assessment||For men: Risk factors for CHD include age, diabetes, total cholesterol level, HDL level, blood pressure, and smoking.
CHD risk estimation tool: http://cvdrisk.nhlbi.nih.gov/calculator.asp
For women: Risk factors for ischemic stroke include age, high blood pressure, diabetes, smoking, history of CVD, atrial fibrillation, and left ventricular hypertrophy.
|Relevant Recommendations from the USPSTF||The USPSTF has made recommendations on screening for abdominal aortic aneurysm, carotid artery stenosis, coronary heart disease, high blood pressure, lipid disorders, and peripheral arterial disease. These recommendations are available at http://www.uspreventiveservicestaskforce.org.|
Abbreviations: CHD = coronary heart disease, CVD = cardiovascular disease, GI = gastrointestinal, HDL = high-density lipoprotein, MI = myocardial infarction, NSAIDs = nonsteroidal anti-inflammatory drugs.
For the full recommendation statement and supporting documents, please go to: http://www.uspreventiveservicestaskforce.org.
Disclaimer: Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services.
Copyright and Source Information
This document is in the public domain within the United States.
Requests for linking or to incorporate content in electronic resources should be sent via the USPSTF contact form.
Internet Citation: Clinical Summary: Aspirin for the Prevention of Cardiovascular Disease: Preventive Medication. U.S. Preventive Services Task Force. March 2016.